A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma

European Urology Focus - Tập 4 - Trang 995-1001 - 2018
Ricardo Leão1, Madhur Nayan1, Nahid Punjani2, Michael A.S. Jewett1, Kamel Fadaak1, Juan Garisto1, Jeremy Lewin3, Eshetu G. Atenafu4, Joan Sweet5, Lynn Anson-Cartwright1, Peter Boström6, Peter Chung7, Padraig Warde7, Philippe L. Bedard3, Aditya Bagrodia8, Yuval Freifeld8, Nicholas Power9, Eric Winquist2, Robert J. Hamilton1
1Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada
2Division of Urology, Western University and London Health Sciences Centre, London, ON, Canada
3Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Department of Medicine, University of Toronto, Toronto, ON, Canada
4Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
5Department of Pathology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada
6Department of Urology, Turku University Hospital, Turku, Finland
7department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada
8Division of Urology, UT Southwestern Medical Center, Dallas, TX, USA
9Division of Medical Oncology, Western University and London Health Sciences Centre, London, ON, Canada

Tài liệu tham khảo

Le Cornet, 2014, Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data, Eur J Cancer, 50, 831, 10.1016/j.ejca.2013.11.035 National Cancer Institute. SEER cancer stat facts: testiscancer 2017. Horwich, 2006, Testicular germ-cell cancer, Lancet, 367, 754, 10.1016/S0140-6736(06)68305-0 Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, 136, E359, 10.1002/ijc.29210 Albers, 2012, EAU guidelines on testicular cancer: 2011 update. European Association of Urology, Acta Urol Esp, 36, 127, 10.1016/j.acuro.2011.06.017 Kollmannsberger, 2010, Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery, J Clin Oncol, 28, 537, 10.1200/JCO.2009.23.0755 Jewett, 2011, Words of wisdom. Re: management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery, Eur Urol, 59, 880, 10.1016/j.eururo.2011.02.013 Krege, 2008, European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II, Eur Urol, 53, 497, 10.1016/j.eururo.2007.12.025 Steyerberg, 1995, Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups, J Clin Oncol, 13, 1177, 10.1200/JCO.1995.13.5.1177 Krege, 2008, European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I, Eur Urol, 53, 478, 10.1016/j.eururo.2007.12.024 Beck, 2006, Long-term outcome of retroperitoneal lymph node dissection in the management of testis cancer, World J Urol, 24, 267, 10.1007/s00345-006-0060-8 Albers, 2004, Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group, J Urol, 171, 1835, 10.1097/01.ju.0000119121.36427.09 Heidenreich, 2009, Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection, Eur Urol, 55, 217, 10.1016/j.eururo.2008.09.027 Vergouwe, 2001, Validation of a prediction model and its predictors for the histology of residual masses in nonseminomatous testicular cancer, J Urol, 165, 84, 10.1097/00005392-200101000-00021 Onozawa, 2004, Clinical parameters that predict histology of postchemotherapy retroperitoneal lymph node mass in testicular cancer, Int J Urol, 11, 535, 10.1111/j.1442-2042.2004.00832.x Oldenburg, 2003, Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses, J Clin Oncol, 21, 3310, 10.1200/JCO.2003.03.184 Vergouwe, 2007, Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients, Eur Urol, 51, 424, 10.1016/j.eururo.2006.06.047 Punjani, 2016, Validation of a prediction model for avoiding post-chemotherapy retroperitoneal lymphadenectomy in patients with metastatic non-seminomatous cancer, Can Urol Assoc J, 10, 260, 10.5489/cuaj.3558 Nayan, 2016, Medication use and survival in diabetic patients with kidney cancer: a population-based cohort study, Pharmacol Res, 113, 468, 10.1016/j.phrs.2016.09.027 Royston, 2005, Building multivariable regression models with continuous covariates in clinical epidemiology—with an emphasis on fractional polynomials, Methods Inf Med, 44, 561, 10.1055/s-0038-1634008 Austin, 2014, Using fractional polynomials to model the effect of cumulative duration of exposure on outcomes: applications to cohort and nested case-control designs, Pharmacoepidemiol Drug Saf, 23, 819, 10.1002/pds.3607 Harrell, 1982, Evaluating the yield of medical tests, JAMA, 247, 2543, 10.1001/jama.1982.03320430047030 Hosmer, 1989 Ravi, 2014, A meta-analysis of patient outcomes with subcentimeter disease after chemotherapy for metastatic non-seminomatous germ cell tumor, Ann Oncol, 25, 331, 10.1093/annonc/mdt425 Sheinfeld, 2002, The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controversies, Semin Urol Oncol, 20, 262, 10.1053/suro.2002.36977 Toner, 1990, Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection, J Clin Oncol, 8, 1683, 10.1200/JCO.1990.8.10.1683 Schultz, 1989, Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience, J Clin Oncol, 7, 1497, 10.1200/JCO.1989.7.10.1497 Einhorn, 1997, Do all germ cell tumor patients with residual masses in multiple sites require postchemotherapy resections?, J Clin Oncol, 15, 409, 10.1200/JCO.1997.15.1.409 Debono, 1997, Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors, J Clin Oncol, 15, 1455, 10.1200/JCO.1997.15.4.1455 Fossa, 1992, Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?, J Clin Oncol, 10, 569, 10.1200/JCO.1992.10.4.569
Thông tin
Thông tin xuất bản

European Urology Focus

Tập 4

995-1001

Thông tin tác giả